SEC Form D private-offering filing
Optimvia, LLC
A new SEC Form D private-offering notice from Cincinnati, OH, a $500,000 filer-stated offering target in Biotech. The source filing is one click away.
Biopharmaceutical company using its ADEPT enzyme engineering platform to manufacture biosynthetic heparin without animal sourcing.
Filed 2026-04-08Filed to raise $500,000First money in 2026-03-26Raised so far $75,000HQ (as filed) Cincinnati, OHSector Biotech ✓Stage (inferred) Pre-seedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified optimvia.com↗Named in the filing 4 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.